Cholestasis and the role of basolateral efflux pumps

Zeitschrift fur Gastroenterologie

Volumn 49, Issue 12, 2011, Pages 1553-1557

  Keppler, D ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

ATP dependent transport; basolateral hepatocyte membrane; bile acids; bile flow; bile salt export pump (BSEP; ABCB11); cholestasis; intrahepatic cholestasis

Indexed keywords

ABC TRANSPORTER; ATP BINDING CASETTE B11; BILE ACID; CARRIER PROTEIN; GLUTATHIONE; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; MULTIDRUG RESISTANCE PROTEIN 4; UNCLASSIFIED DRUG;

ARTICLE; BASOLATERAL EFFLUX PUMP; BILE FLOW; BILE SALT EXPORT PUMP; BILE SECRETION; CHOLESTASIS; GENETIC VARIABILITY; HUMAN; INTRACELLULAR TRANSPORT; LIVER CELL; LIVER SINUSOID; MEMBRANE TRANSPORT; NONHUMAN; PROTEIN TRANSPORT; URINARY EXCRETION;

ANIMALS; BILE; BILE DUCTS; CHOLESTASIS; HUMANS; MEMBRANE TRANSPORT PROTEINS; MODELS, BIOLOGICAL;

EID: 82955184472     PISSN: 00442771     EISSN: 14397803     Source Type: Journal    
DOI: 10.1055/s-0031-1281755     Document Type: Article

References (63)

1. Kitamura T, Jansen P, Hardenbrook C et al. Defective ATP-dependent bile canalicular transport of organic anions in mutant (TR-) rats with conjugated hyperbilirubinemia. Proc Natl Acad Sci USA 1990 87 3557-3561
2. Ishikawa T, Mller M, Klnemann C et al. ATP-dependent primary active transport of cysteinyl leukotrienes across liver canalicular membrane. Role of the ATP-dependent transport system for glutathione S-conjugates. JBiol Chem 1990 265 19279-19286
3. Adachi Y, Kobayashi H, Kurumi Y et al. ATP-dependent taurocholate transport by rat liver canalicular membrane vesicles. Hepatology 1991 14 655-659
4. Mller M, Ishikawa T, Berger U et al. ATP-dependent transport of taurocholate across the hepatocyte canalicular membrane mediated by a 110-kDa glycoprotein binding ATP and bile salt. JBiol Chem 1991 266 18920-18926 (Pubitemid 21908171)
5. Nishida T, Gatmaitan Z, Che M et al. Rat liver canalicular membrane vesicles contain an ATP-dependent bile acid transport system. Proc Natl Acad Sci USA 1991 88 6590-6594 (Pubitemid 21914993)
6. Meier P J., Meier-Abt A, Barrett C et al. Mechanisms of taurocholate transport in canalicular and basolateral rat liver plasma membrane vesicles. JBiol Chem 1984 259 10614-10622 (Pubitemid 14064165)
7. lnoue M, Kinne R, Tran T et al. Taurocholate transport by rat liver canalicular membrane vesicles. JClin Invest 1984 73 659-663
8. Keppler D, Arias I M. Introduction: Transport across the hepatocyte canalicular membrane. FASEB J 1997 11 15-18
9. Keppler D. Multidrug Resistance Proteins (MRPs, ABCCs): Importance for Pathophysiology and Drug Therapy. In: Fromm M F. Kim R B. (eds) Drug Transporters; Handbook of Experimental Pharmacology, Vol. 201. Heidelberg Springer 2011 299-323
10. Keppler D. Uptake and efflux transporters for conjugates in human hepatocytes. Methods Enzymol 2005 201 531-542 (Pubitemid 43052438)
11. Nies A T., Schwab M, Keppler D. Interplay of conjugating enzymes with OATP uptake transporters and ABCC/MRP efflux pumps in the elimination of drugs. Expert Opin Drug Metab Toxicol 2008 4 545-568 (Pubitemid 351890738)
12. Stieger B. The Role of the Sodium-Taurocholate Cotransporting Polypeptide (NTCP) and of the Bile Salt Export Pump (BSEP) in Physiology and Pathobiology of Bile Formation. In: (eds) Drug Transporters; Handbook of Experimental Pharmacology, Vol. 201. Heidelberg Springer 2011 205-259
13. König J. Uptake Transporters of the Human OATP Family. Molecular Characteristics, Substrates, Their Role in Drug-Drug Interactions, and Functional Consequences of Polymorphisms. In: (eds) Drug Transporters; Handbook of Experimental Pharmacology, Vol. 201. Heidelberg Springer 2011 1-28
14. Nies A T., Keppler D. The apical conjugate efflux pump ABCC2 (MRP2). Pflgers Arch Eur J Physiol 2007 453 643-659 (Pubitemid 46192536)
15. Arrese M, Trauner M. Molecular aspects of bile formation and cholestasis. Trends Mol Med 2003 9 558-564 (Pubitemid 38017195)
16. Oude Elferink R P., Paulusma C C., Groen A K. Hepatocanalicular transport defects: pathophysiologic mechanisms of rare diseases. Gastroenterology 2006 130 908-925 (Pubitemid 43374538)
17. Pauli-Magnus C, Meier P J. Hepatobiliary transporters and drug-induced cholestasis. Hepatology 2006 44 778-787 (Pubitemid 46489540)
18. Paulusma C C., Bosma P J., Zaman G JR et al. Congenital jaundice in rats with a mutation in a multidrug resistance associated-protein gene. Science 1996 271 1126-1127
19. Bchler M, König J, Brom M et al. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMRP, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. JBiol Chem 1996 271 15091-15098 (Pubitemid 26197579)
20. Jansen P LM, Peters W HM, Lamers W H. Hereditary chronic conjugated hyperbilirubinemia in mutant rats caused by defective hepatic anion transport. Hepatology 1985 5 573-579 (Pubitemid 15029725)
21. Böhme M, Mller M, Leier I et al. Cholestasis caused by inhibition of the adenosine triphosphate-dependent bile salt transport in rat liver. Gastroenterology 1994 107 255-265 (Pubitemid 24195369)
22. Kubitz R, Keitel V, Hussinger D. Inborn errors of biliary canalicular transport systems. Methods Enzymol 2005 400 558-569 (Pubitemid 43052440)
23. Keitel V, Burdelski M, Warskulat U et al. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis. Hepatology 2005 41 1160-1172 (Pubitemid 40593925)
24. Strautnieks S S., Byrne J A., Pawlikowska L et al. Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families. Gastroenterology 2008 134 1203-1214
25. Keitel V, Burdelski M, Vojnisek Z et al. De novo bile salt transporter antibodies as a possible cause of recurrent graft failure after liver transplantation: a novel mechanism of cholestasis. Hepatology 2009 50 510-517
26. Jara P, Hierro L, Martinez-Fernandez P et al. Recurrence of bile salt export pump deficiency after liver transplantation. N Engl J Med 2009 361 1359-1367
27. Oude Elferink R PJ, Ottenhoff R, Liefting W et al. Hepatobiliary transport of glutathione and glutathione conjugate in rats with hereditary hyperbilirubinemia. JClin Invest 1989 84 476-483 (Pubitemid 19196978)
28. Proost J H., Nijssen H MJ, Strating C B. et al. Pharmacokinetic modeling of the sinusoidal efflux of anionic ligands from the isolated perfused rat liver: the influence of albumin. JPharmacokinet Biopharm 1993 21 375-394 (Pubitemid 24025266)
29. König J, Rost D, Cui Y et al. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology 1999 29 1156-1163 (Pubitemid 29168750)
30. Rius M, Nies A T., Hummel-Eisenbeiss J et al. Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane. Hepatology 2003 38 374-384 (Pubitemid 36919858)
31. Keppler D, König J, Nies A T. Conjugate export pumps of the multidrug resistance protein (MRP) family in liver. In: Arias I M. Boyer J L. Chisari F V. (eds). The Liver: Biology and Pathobiology. New York Lippincott Williams & Wilkins 2001 373-382
32. Akita H, Suzuki H, Hirohashi T et al. Transport activity of human MRP3 expressed in Sf9 cells: comparative studies with rat MRP3. Pharm Res 2002 19 34-41 (Pubitemid 34075104)
33. Lee Y M., Cui Y, König J et al. Identification and functional characterization of the natural variant MRP3-Arg1297His of human multidrug resistance protein 3 (MRP3/ABCC3). Pharmacogenetics 2004 14 213-223 (Pubitemid 38530513)
34. Rius M, Hummel-Eisenbeiss J, Hofmann A F. et al. Substrate specificity of human ABCC4 (MRP4)-mediated cotransport of bile acids and reduced glutathione. Am J Physiol Gastrointest Liver Physiol 2006 290 G640-G649
35. Kruh G D., Belinsky M G. The MRP family of drug efflux pumps. Oncogene 2003 22 7537-7552 (Pubitemid 37487175)
36. Zelcer N, Reid G, Wielinga P et al. Steroid and bile acid conjugates are substrates of human amultidrug-resistance protein (MRP) 4 (ATP-binding cassette C4). Biochem J 2003 371 361-367 (Pubitemid 36547618)
37. Russel F G., Koenderink J B., Masereeuw R. Multidrug resistance protein 4 (MRP4/ABCC4):a versatile efflux transporter for drugs and signalling molecules. Trends Pharmacol Sci 2008 29 200-207
38. Rius M, Hummel-Eisenbeiss J, Keppler D. ATP-dependent transport of leukotrienes B4 and C4 by the multidrug resistance protein ABCC4 (MRP4). JPharmacol Exp Ther 2008 324 86-94 (Pubitemid 350294174)
39. Mayer R, Kartenbeck J, Bchler M et al. Expression of the MRP gene-encoded conjugate export pump in liver and its selective absence from the canalicular membrane in transport-deficient mutant hepatocytes. JCell Biol 1995 131 137-150
40. Keppler D, Kartenbeck J. The canalicular conjugate export pump encoded by the cmrp/cmoat gene. In: Boyer J L. Ockner R K. (eds). Progress in Liver Diseases. Philadelphia Saunders 1996 55-67 (Pubitemid 26381335)
41. Donner M G., Keppler D. Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver. Hepatology 2001 34 351-359 (Pubitemid 32702348)
42. Soroka C J., Lee J M., Azzaroli F et al. Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver. Hepatology 2001 33 783-791 (Pubitemid 32246625)
43. Wagner M, Fickert P, Zollner G et al. Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. Gastroenterology 2003 125 825-838 (Pubitemid 37070700)
44. Jemnitz K, Veres Z, Vereczkey L. Contribution of high basolateral bile salt efflux to the lack of hepatotoxicity in rat in response to drugs inducing cholestasis in human. Toxicol Sci 2010 115 80-88
45. Wang R, Chen H L., Liu L et al. Compensatory role of P-glycoproteins in knockout mice lacking the bile salt export pump. Hepatology 2009 50 948-956
46. Chai J, Luo D, Wu X et al. Changes of organic anion transporter MRP4 and related nuclear receptors in human obstructive cholestasis. JGastrointest Surg 2011 15 996-1004
47. Fröhling W, Stiehl A. Bile salt glucuronides: identification and quantitative analysis in the urine of patients with cholestasis. Eur J Clin Invest 1976 6 67-74
48. Stiehl A, Raedsch R, Rudolph G et al. Biliary and urinary excretion of sulfated, glucuronidated and tetrahydroxylated bile acids in cirrhotic patients. Hepatology 1985 5 492-495 (Pubitemid 15065960)
49. Takikawa H, Beppu T, Seyama Y. Urinary concentrations of bile acid glucuronides and sulfates in hepatobiliary diseases. Gastroenterol Jpn 1984 19 104-109 (Pubitemid 14118851)
50. Back P. Bile acid glucuronides. Isolation and identification of a chenodeoxycholic acid glucuronide from human plasma in intrahepatic cholestasis. Hoppe Seylers Z Physiol Chem 1976 357 213-217
51. Marschall H U., Wagner M, Zollner G et al. Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans. Gastroenterology 2005 129 476-485 (Pubitemid 41096635)
52. Keppler D, Rius M. The concept of basolateral efflux pumps of the hepatocyte. In: Keppler D (eds). Bile Acids: Biological Actions and Clinical Relevance. Dordrecht Springer and Falk Foundation 2007 48-52
53. Rius M, Nies, AT et al,. Bile salt and glutathione coefflux mediated by multidrug resistance protein MRP4 (ABCC4), a basolateral transporter of the hepatocyte. In: Paumgartner G (eds), Bile Acid Biology and its Therapeutic Implications; Dordrecht Springer 2005 101-106
54. Ballatori N, Christian W V., Lee J Y. et al. OST-OST: a major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia. Hepatology 2005 42 1270-1279 (Pubitemid 43260029)
55. Trauner M, Halilbasic E. Nuclear receptors as new perspective for the management of liver diseases. Gastroenterology 2011 140 1120-1125
56. Pauli-Magnus C, Meier P J., Stieger B. Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy. Semin Liver Dis 2010 30 147-159
57. Cui Y, König J, Leier I et al. Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. JBiol Chem 2001 276 9626-9630
58. Cui Y, König J, Keppler D. Vectorial transport by double-transfected cells expressing the human uptake transporter SLC21A8 and the apical export pump ABCC2. Mol Pharmacol 2001 60 934-943 (Pubitemid 33027428)
59. Martnez-Ans E, Castillo J E., Dez J et al. Immunohistochemical detection of chloride/bicarbonate anion exchangers in human liver. Hepatology 1994 19 1400-1406 (Pubitemid 24166460)
60. Beuers U, Hohenester S, Buy Wenniger L J. et al. The biliary HCO3- umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies. Hepatology 2010 52 1489-1496
61. Stefan C de, Jansen S, Bollen M. NPP-type ectophosphodiesterases: unity in diversity. Trends Biochem Sci 2005 30 542-550 (Pubitemid 41356492)
62. Kremer A E., Martens J JWW, Kulik W et al. Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology 2010 139 1008-1018
63. Watanabe N, Tsukada N, Smith C R. et al. Motility of bile canaliculi in the living animal: implications for bile flow. JCell Biol 1991 113 1069-1080 (Pubitemid 21909739)